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Identity 
Other names: Currarino triad; ASP (Anal atresia, 
sacral anomalies, presacral mass); Sacral defect with 
Anterior Meningocoele 
Note: Currarino syndrome is a multiple congenital 
anomalies syndrome characterized by partial agenesis 
of the sacrum in association with pelvic malformation. 
Anal atresia and the presence of a pre-sacral mass 
(teratoma and/or anterior meningocoele) make up the 
so called Currarino triad. Other malformations, such as 
renal (35%) and gynaecological (19%) are common. 
Hirschsprungs disease has also been recorded. Other 
rarer complications include pelvic abcess, malignant 
degeneration of a pre-sacral teratoma, E Coli ascending 
meningitis and spinal cord tethering. Recurrence of a 
benign teratoma has been recorded. Urinary 
incontinence, dysmenorrhoea, dyspareunia, poor 
sphincter control, sacral anaesthesia and headaches 
precipitated by coughing or straining have been 
reported. 
Inheritance: Autosomal dominant. De novo mutations 
have been recorded and account for approximately 15% 
of cases. 
Clinics 
Currarino syndrome was described as a triad by Guido 
Currarino, an American radiologist in 1981. The triad 
consists of:  
- Sickle shaped sacrum; 
- Pre-sacral mass (meningocoele and / or tumour 
(teratoma; hamartoma); 
- Anal atresia. 
The term Currarino syndrome is preferred as it is now 
known that there are other components to this genetic 
disorder. Bowel obstruction in infancy or chronic 
constipation in childhood are the commonest presenting 
symptoms. Gynaecological and renal malformation are 
commonly described. Hirschsprungs disease and 
meningitis (often E. Coli ascending meningitis) have 
been recorded. Perianal sepsis, which is found in at 
least 10% of patients, can indicate the presence of an 
underlying presacral mass. Tumour development within 
the teratoma has been documented. 
A report describing Currarino syndrome with 
ventriculomegaly due to a Arnold-Chiari type II 
malformation must be interpreted with caution. The 
affected child was dysmorphic with hypertelorism, a 
short enlarged neck and camptodactyly. The mother 
and brother also had Currarino syndrome without these 
added features. It is quite possible that this child ad 
two co-existing disorders, one the Currarino inherited 
from a mother with typical features and secondly a de 
novo Arnold-Chiari type II malformation. 
As with many dominant disorders the phenotype is very
variable. It is estimated that approximately 50% of 
those who inherit the gene will present with the sever  
phenotype (requiring surgery), 25% will have 
symptoms albeit milder and 25% will be asymptomatic 
heterozygotes. 
Neoplastic risk 
The presacral mass associated with the Currarino trad
may be a teratoma, hamartoma, neuroenteric cyst, 
anterior meningocoele or a combination of these thre. 
A teratoma is a neoplasm originating from primordial 
germ cells and is derived from all three embryonal 
germ layers. 
A hamartoma is a mass produced by disorganized local 
tissue growth and can contain all three germ layers. 
A teratoma carries a risk for germ cell malignancy, a 
hamartoma does not. 
It has been argued that the reason the risk for malignant 
degeneration in Currarino syndrome is low is because 
most of these pre-sacral masses which have previously 
been classified as teratomas are more likely to be 
hamartomas. In those rare instances where malignancy 
has been recorded it is possible that this could have 
resulted from a secondary carcinoma developing in a
Currarino syndrome 
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Figure A: Pelvic x ray of adult female showing a scimitar sacrum with a right sided defect. In our cohort, 38% had a sickle shaped 
sacrum with a left sided defect and 37% had a similar sickle shaped sacrum with a right sided defect. 
Figure B: Pelvic x ray of male child showing a left sided sacral defect with associated faecal loading. Courtesy Sally Ann Lynch, 
reprinted from J Med Genet. 2000; 37:561-566 by permission of the publisher BMJ Publishing Group Ltd of the BMA.  
 
Figure A: CT scan of pelvis showing a large anterior meningocele filling with contrast (this is the same patient as shown in fig 1A). 
Figure B: CT of pelvis of adult female showing gross distortion of pelvic anatomy with an abnormal sacral bone and a presacral mass. 
Courtesy Sally Ann Lynch, reprinted from J Med Genet. 2000; 37:561-566 by permission of the publisher BMJ Publishing Group Ltd of 
the BMA. Table 1 summary of the malignant tumours reported in the literature. 
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Table 1 summary of the malignant tumours reported in the literature. 
chronically inflamed hamartoma rather than a germ cell 
malignancy. 
Malignant change of the pre-sacral tumour has been 
described but is a rare occurance. The histological 
appearances are varied and often poorly described 
particularly in the older literature. 
A 32 year old women, who was known to have a pre-
sacral teratoma, died from metastatic spread of the 
tumour. Histological findings were not included in the 
report (Ashcraft, 1973; same patient also reported by 
Hunt, 1977). 
A 54 year old male from a known Currarino family was 
diagnosed with a presacral mass. This was shown to be
a teratoma which had undergone malignant change. A 
relative of this man, aged 14 years, who had been 
treated for a rectal stricture, died from a brain tumour, 
no histology was available. (Yates et al., 1983). 
A child who died from probable brain metastases was
reported in a large Irish pedigree (O'Riordain et al., 
1991). Histology was not available and the child di
not have a post mortem. This child had presented at 
birth with a pre-sacral mass and had surgery. The 
presacral teratoma recurred at aged 4 years and she 
died from a brain tumour shortly afterwards. 
A female infant who had complete excision of a benign 
pre-sacral teratoma aged 14 months had a recurrence of 
a pre-sacral mass at aged 2 ( Tander et al., 1999). 
Histology confirmed recurrence of the teratoma with 
malignant transformation. The AFP level was 
extremely high. Treatment was by excision and 
chemotherapy (bleomycin, etopside and cis-platin) but 
unfortunately the tumour recurred after 12 months Se
responded to the same course of chemotherapy but an 
aggressive recurrence at age 4 years did not respond to 
treatment and she died from pulmonary metastases. 
A 22 year old male was reported who developed a 
malignant neuroectodermal tumour arising from a pre-
sacral mass, (Urioste, 2004). He had previously been 
asymptomatic. He presented with a painless abdominal 
swelling. A CT scan showed multiple cysts in the liver 
and it was thought he had isolated liver cystic disease. 
Lytic pelvic lesions were identified 1 year later on CT 
and a biopsy of one of these lesions confirmed a well 
differentiated neuroendocrine tumour. A presacral mss 
was identified in follow up scans suggestive of a 
presacral mass with malignant transformation. Biopsy 
of the mass and the liver confirmed the presence of a
neuroendocrine tumour. Chemotherapy was ineffective 
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and he subsequently died. Autopsy confirmed tumour 
invasion of the liver, pancreas, kidneys and mesenteric 
lympth nodes. The pre-sacral mass was comprised of 
neoplastic tissue, teratoma, muscle and fibroadipous 
tissue. 
A 4 year old girl was reported with Currarino syndrome 
who developed an ectopic nephroblastoma and 
pulmonary metastases from a presacral mass 
(Martucciello, 2004). She died despite chemo and 
radiotherapy. 
A 2 year old girl developed a malignant teratoma from 
a pre-existing presacral mass (Cretolle et al., 2006). 
She was well following chemotherapy. 
A 3 year old girl was reported with a malignant tumour 
arising within a teratoma (Sen et al., 2006). Histology 
revealed the presence of two components; residual 
mature teratoma and a necrotic malignant tumour 
resembling a primitive peripheral neuroectodermal 
tumour. A chemotherapy regimen according to the 
Euro Ewing 99 protocol was given in addition to 
radiotherapy. She remained well 8 months following 
her treatment. 
One report of leiomyosarcoma in a grandmother of an 
affected child with Currarino has been reported 
(Norum, 1991). 
In addition, a further case of Leiomyomatosis 
peritonealis disseminate (LPD) in a 27 year old female 
with Currarino syndrome has been described in the 
literature (Nappi, 2006). Malignant degeneration of 
LPD to a leiomyosarcoma has been reported but is rare.
A sacrococcygeal teratoma has been described with a 
deletion of chromosome 7q, partial trisomy 2p. 
Malignant degeneration had not occurred and the child 
died from post-operative complications (Le Caignec, 
2003). This teratoma was a posterior teratoma and 
similar to the type often identified antenatally. It is 
thought to have a different genetic basis to the 
teratomas seen in the Currarino syndrome. No 
mutations in the HLXB9 gene have been found in such 
cases. It is therefore interesting that this child had 
deleted the HLXB9 gene suggesting some genetic 
relationship between both conditions. 
In classical Currarino syndrome the pre-sacral mass 
tends to be anterior to the sacrum. The sacrococcygeal 
teratomas have appeared to be a different group in that 
they present in the posterior coccygeal region, are often 
sporadic, occur more commonly in females and 
commonly become malignant. Mutational analysis of 
the HLXB9 gene has been negative in a number of 
cases. This recent case is interesting as it does sugge t 
that HLXB9 is involved in some cases of posterior 
teratomas (the gene was shown to be deleted in this 
case) in some cases. 
Treatment 
Symptomatic: those children who present at birth with 
imperforate anus will require emergency surgery.  
Surgery for the pre-sacral mass is usually advised. The 
mass can cause an obstruction or other symptoms such 
as ascending meningitis if an enteric fistula is present. 
There is also the risk of malignant transformation. 
Treatment of the mass if it undergoes malignant 
transformation involves both a surgical and 
chemothereputic approach. Bleomycin, etoposide and 
carboplatin are now the gold standard 
chemotherapeutic treatments. Carboplatin has recently 
replaced cisplatin as it is less nephro and ototoxic. 
Some patients may develop symptoms as a result of 
their renal or gynaecological malformation and these 
need to be managed appropriately. Spinal cord 
tethering is recognized and may recur requiring long 
term surveillance. Many individuals suffer from 
chronic constipation. Patients with a pre-sacral mass, 
particularly those with an anterior meningocoele, can 
develop headaches if pressure is increased within the 
abdominal cavity from coughing or sneezing or by 
lying on their abdomens. 
Evolution 
In those children where this condition is diagnosed at 
birth, a good clinical plus radiological assessment 
(including pelvic MRI) will identify most of the 
malformations. Surgery should be considered if a 
presacral mass is present. 
Many of the complications listed above can be avoided 
if appropriate action is taken in early childhood. 
Prognosis 
Generally very good. In some patients a colostomy bag 
is required for life. Some women can present symptos 
from their gynaecological malformation and require 
assessment and occasionally treatment for this. Spinal 
cord tethering can be another debilitating problem that
can recur despite treatment. 
If malignant transformation occurs chemotherapy can
be effective but recurrences can occur which are 
resistant to treatment. There are no case reports 
recording a long remission but as the case reports are o 
few it is not possible to give definitive prognostic 
indicators. People have reported recurrence of a 
teratoma and therefore it is possible that malignancy 
could occur even if surgery has removed a presacral 
teratoma. However, the malignancy risk, which is 
already very small must be reduced even further by 
elective removal of any pre-sacral mass. 
Cytogenetics 
Cytogenetic analysis will be normal in most cases. 
However, some cases are associated with a 7q36 
deletion or a translocation involving this region. It is 
worth considering FISH analysis of 7q36 in cases 
where Currarino syndrome is associated with 
developmental delay. 
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Cytogenetics of cancer  
There is no information on the cytogenetic analysis of 
the pre-sacral tumours. 
Genes involved and Proteins 
HLXB9 
Location: 7q36 
Note: HLXB9 is a Homeobox gene. Proteins encoded 
by homeobox-containing genes are sequence-specific 
DNA binding proteins implicated in the control of gene 
expression in both developing and adult tissues. 
DNA/RNA 
Description: The HLXB9 gene has 3 exons. The 
phenotype results from haploinsufficiency of this gene. 
Protein 
Description: The three exons encode a 403 amino acid 
protein containing a homeodomain preceded by a very
highly conserved 82 amino acid domain. The remainder 
of the protein is not well conserved. This second highly 
conserved 82 amino acid domain encoded by HLXB9 
may have a regulatory role and/or be involved in 
protein-protein associations. Amino acid substitutions 
in this area could conceivably give rise to different 
clinical phenotypes. 
There is a polyalanine region consisting of 16 alanines. 
There are population differences in the polyalanine 
domain but little correlation between the presence of 
disease or the variable penetrance of disease and the 
number of GCC repeats in patients. 
Expression:  In humans, studies have shown expression 
in the basal plate of the spinal cord and hindbrain and 
in the pharynx, oesophagus, stomach and pancreas and 
lymphoid tissue. Significant spatial and temporal 
expression differences were evident when expression of 
the gene in human and mouse were compared which 
may explain the phenotypic disparities observed 
between the two species. 
Tailbud expression has been noted in Xenopus laevis. 
Studies on human embryos demonstrated expression in 
the sacral region during embryogenesis albeit 
predominantly in the anterior horn regions of the spinal 
cord. In adults the HLXB9 gene is predominantly 
expressed in the pancreas. 
A mouse model of the Currarino triad demonstrated 
that abnormal differentiation of the tail bud 
mesenchyme led to defects of the tailgut and neural 
tube. Etretinate (the teratogenic agent used) disrupted 
secondary neurulation and resulted in malformations 
resembling the Currarino triad. The cloacal plate 
appeared to play a critical role in the development of 
the anorectum and deficiencies of this caused anorectal 
malformation. 
Function:  The HLXB9 gene functions as a 
transcription factor regulating gene expression in both 
developing and adult tissues. Little is known about 
target genes or protein partners. 
Homology: The HLXB9 sequence shows up to 96%, 
91% and 80% identity to orthologues in mouse, chick 
and Xenopus respectively. Sequence homology to 
Drosphilia homeobox genes and to the human 
homeobox gene PDX-1 suggest that some mutations 
within the HLXB9 homeodomain may alter the DNA 
binding specificity while other mutations may reduce 
nuclear translocation of the mutated protein. 
Mutations 
Note: Nonsense, frameshift and missense mutations 
have been identified. Most mutations are located within 
exon 1 and the homeodomain. Most missense 
mutations are clustered in the homeodomain whereas 
nonsense and frameshift mutations are mostly on the 
NH2 terminus of the protein. There is poor genotype 
phenotype correlation. Reduced penetrance has also 
been recorded by several groups. It appears, from in 
vitro assays that the missense mutations disrupt the 
binding of the homeodomain to the target DNA motif 
TAAT. 
Whilst mutations have been identified in almost all the 
familial cases, it appears that mutations are only found 
in 30% of sporadic cases. Somatic mosaicism is most 
favoured explanation. It is also possible that mutations 
might be present outside of the coding region and 
genetic heterogeneity remains a possibility. 
Germinal: There have been no recorded cases of germ
line mosaicism. 
Somatic:  There have been no recorded cases of 
somatic mosaicism. 
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